Nalu Bio is a biotech company creating a new category of chemistry-based cannabinoids for the consumer and pharmaceutical markets. Nalu Bio has developed a proprietary, flexible chemistry platform that is setting a new industry standard for purity, quality, and sustainability. Nalu Bio's proprietary approach creates identical batches of any known cannabinoid, setting the standards for consistency and quality, because it removes the risk of contamination from pesticides, heavy metals, and THC inherent in hemp extraction. Our unique, scalable platform has the ability to keep pace with anticipated market expansion, and will reliably deliver high quality and widely-accessible cannabinoids to global consumer and pharmaceutical markets.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
02/28/23	$12,000,000	Series A	Axial VC Bonaventure Equity Brown Angel Group Flybridge Capital Partners Golden Seeds Intrinsic Capital Partners L37 Portfolia Sacramento Angels	undisclosed